Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT07265908
Enrolling by invitation Observational

Biobank Aimed to Study Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies

NCT07265908 · tracked via the Priya Life Science Italy tracker
Sponsor
IRCCS San Raffaele
Phase
Observational
Started
2024-04-09
Last updated
2025-12-05

Condition(s) studied

Gynecological DisordersMale InfertilityFemale InfertilityPregnancy

Investigational drug(s) / intervention(s)

Blood sampling

Blood sampling: Blood sampling

Study summary

The REPRO-Biobank has been established at San Raffaele Hospital in Milan for the purpose of collecting and preserving human biological samples and associated data. Its primary objective is to support biomedical research, with a particular focus on advancing scientific knowledge - including in the field of genetics - related to gynecological disorders, male and female infertility, and pregnancy-related conditions.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
1. Affected participants Inclusion Criteria for adult patients (including pregnant and breastfeeding women) and pediatric patients affected by: * Male infertility * Female infertility * Gynecological disorders * Pregnancy-related conditions * Conditions requiring fertility preservation treatment (oocyte cryopreservation, ovarian tissue preservation) * Informed consent signed by the adult patient or by the parents/legal guardians of pediatric patients Exclusion Criteria * Patients unable or unwilling to sign the informed consent 2. Healthy participants Inclusion Criteria * Healthy adult subjects (including pregnant and lactating women) * Able to give informed consent for participation in the study Exclusion Criteria * Patients unable or unwilling to sign the informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Irccs San Raffaele Hospital Milan Milan

More IRCCS San Raffaele trials in Italy

Effects of Combined Aerobic and Cognitive Training in a Simultaneous or Sequential Paradigm on Cognition and Brain Functional Activity in Patients with AMCI Active, not recruiting
Dissecting the Molecular and Cellular Pathophysiology of Sarcopenic Obesity in the Elderly Recruiting
Intervention on New Onset-T1D Children Recruiting
The Aim of the Study is to Characterize Patients Exhibiting Muscular Atrophy and Weakness Who Require a Muscle Biopsy for Diagnosis (IBM vs Atypical MND), Through an Innovative Technique Which Enables the Evaluation of the Neuromuscular Junction Involvement in Each Condition Active, not recruiting
Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas Recruiting

Other trials for the same condition

Day-4 Embryo Defragmentation: Blastocyst Rate and clInical Outcomes Recruiting
Comparison of Echo-assisted ALR Technique and Traditional ALR Technique for the Placement of an Epidural Catheter in the Obstetric Patient Recruiting
PREgnancy and FERtility Registry Recruiting
Comparison of Bone Mineral Density in the Third Trimester Between Women in Singleton and Twin Pregnancies Using Questionnaires and REMS Densitometric Examination Recruiting
Lactoferrin-Based Oral Care for Periodontal Health in Pregnancy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07265908 on ClinicalTrials.gov ↗ ← All trials in Italy